01—Abstract
Summary
Summary of the 8-K filed November 6, 2026. Cited figures are marked; the original filing is the authoritative source.
Humana Inc. (HUM) has released its third-quarter 2026 financial results, reporting a GAAP EPS of $1.33a and an Adjusted loss per share of $0.70.
The company has raised its full-year 2026 Adjusted EPS guidance to at least $9.50b, an increase from the previous guidance of at least $9.00. This positive outlook is supported by strong performance in its Insurance segment, with a benefit ratio of 93.7%, exceeding management's expectations. Strategic growth initiatives are also contributing positively.
Humana reported significant year-to-date patient growth in its CenterWell Senior Primary Care segment (30%c) and Medicaid membership growth (7%), driven by new integrated Duals programs. The company also announced a joint venture with BlackRock, which is expected to enhance balance sheet efficiency and financial flexibility. Humana is focused on its long-term strategy to unlock earnings potential by 2028, underpinned by membership growth, improved Star Ratings, and operational efficiencies.
02—Key points
Key Highlights
- Raised Full Year 2026 Adjusted EPS guidance to 'at least $9.50' from 'at least $9.00'.
- Reported 3Q26 GAAP EPS of $1.33 and Adjusted loss per share of $0.70.
- Insurance segment GAAP benefit ratio was 93.7%, better than guidance of 'slightly above 94%'.
- Year-to-date (YTD) CenterWell Senior Primary Care patient growth of 146,800 (30%).
- YTD Medicaid membership grew by 103,600 (7%), primarily from integrated Duals programs.
- Announced a joint venture with BlackRock to enhance balance sheet efficiency and financial flexibility.
- GAAP EPS guidance for FY 2026 revised to 'at least $15.09' from 'at least $6.52'.
03—Questions
Frequently Asked Questions
What are the key financial results for Humana's third quarter of 2026?
Humana reported a GAAP Earnings Per Share (EPS) of $1.33 and an Adjusted loss per share of $0.70 for the third quarter of 2026. For the year-to-date period, GAAP EPS was $16.84 and Adjusted EPS was $17.17.
How has Humana updated its full-year 2026 earnings guidance?
Humana has raised its full-year 2026 Adjusted EPS guidance to 'at least $9.50', up from the previous expectation of 'at least $9.00'. The GAAP EPS guidance was also revised to 'at least $15.09', significantly higher than the prior estimate of 'at least $6.52'.
What are the growth drivers for Humana's business segments?
The company saw significant growth in its CenterWell Senior Primary Care segment, with a year-to-date patient increase of 30%. Medicaid membership also grew by 7% year-to-date, driven by new integrated Duals programs. The Insurance segment benefited from membership growth in Medicare businesses and higher per member premiums.
What is the significance of the joint venture with BlackRock?
The newly announced joint venture with BlackRock replaces previous joint ventures with Welsh, Carson, Anderson & Stowe. This strategic move is intended to enhance Humana's balance sheet efficiency, provide greater financial flexibility, and achieve a reduced cost of capital, while also supporting future growth initiatives.
04—Continue